NCT03303495: A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
- State
- Under way
- Phase
- Phase 3
- People
- 280 planned
- Started
- 14 Nov 2011
- Primary completion
- 31 Dec 2026
- Arms
- FOLFIRI +/- Bevacizumab
- Results
- None posted
- 14 Nov 2011: Trial started
- 6 Oct 2017: Trial registered